BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33997944)

  • 21. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P; Jiao Y; Hao M; Tang X
    J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization.
    Imam JS; Plyler JR; Bansal H; Prajapati S; Bansal S; Rebeles J; Chen HI; Chang YF; Panneerdoss S; Zoghi B; Buddavarapu KC; Broaddus R; Hornsby P; Tomlinson G; Dome J; Vadlamudi RK; Pertsemlidis A; Chen Y; Rao MK
    PLoS One; 2012; 7(12):e52397. PubMed ID: 23285024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
    Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
    Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway.
    Fu Y; Yao N; Ding D; Zhang X; Liu H; Ma L; Shi W; Zhu C; Tang L
    J Cell Physiol; 2020 Mar; 235(3):2761-2775. PubMed ID: 31531884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
    Li G; Cai M; Fu D; Chen K; Sun M; Cai Z; Cheng B
    Cell Physiol Biochem; 2012; 30(6):1481-90. PubMed ID: 23208072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
    Fang Y; Xue JL; Shen Q; Chen J; Tian L
    Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
    Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X
    J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.
    Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S
    Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway.
    Cheng Y; Li Y; Liu D; Zhang R; Zhang J
    FEBS Lett; 2014 Aug; 588(17):3274-81. PubMed ID: 25064845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
    Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z
    Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prominent Role of miR-942 in Carcinogenesis of Tumors.
    Yadegar N; Dadashi Z; Shams K; Mohammadi M; Abyar M; Rafat M
    Adv Biomed Res; 2022; 11():63. PubMed ID: 36133499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated microRNA-15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3.
    Li GC; Qin XL; Song HH; Li YN; Qiu YY; Cui SC; Wang YS; Wang H; Gong JL
    J Cell Physiol; 2019 Dec; 234(12):22331-22342. PubMed ID: 31140597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process.
    Ghafouri-Fard S; Abak A; Tondro Anamag F; Shoorei H; Majidpoor J; Taheri M
    Biomed Pharmacother; 2021 May; 137():111279. PubMed ID: 33493969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals.
    Li H; He C; Wang X; Wang H; Nan G; Fang L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3163-3171. PubMed ID: 31352788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-5188 augments glioma growth, migration and invasion through an SP1-modulated FOXO1-PI3K/AKT-c-JUN-positive feedback circuit.
    Yi R; Yang S; Lin X; Zhong L; Liao Y; Hu Z; Huang T; Long H; Lin J; Wu Z; Xie C; Ding S; Luo J; Luo Q; Song Y
    J Cell Mol Med; 2020 Oct; 24(20):11800-11813. PubMed ID: 32902145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.